WASHINGTON -- Up to three scans using 18 F-fluorodeoxyglucose-enhanced positron emission tomography (FDG-PET) technology can be covered by Medicare for oncology treatment planning, the Centers for ...
FDG PET imaging measures glucose uptake in the brain. It has long served as a proxy for neuronal health—but is it? In the October 13 Science Translational Medicine, researchers led by Christian Haass ...
For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
18 F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is widely used for tumor staging. This study sought to determine the relationship of preoperative primary tumor SUVmax (tSUVmax) with the ...
Increased prostatic uptake of FDG is associated with a higher risk of Gleason 8 or higher disease. NIAGARA FALLS, Ont.—Fluorodeoxyglucose positron emission tomography (FDG-PET) findings can help ...
Prognostic significance of S100A4 expression in biliary tract cancers. Background: The role of F-18 FDG-PET/CT in gastric cancer is limited because of its low sensitivity. The sensitivity of F-18 ...
An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients -- provided by positron emission tomography (PET) imaging -- can guide doctors in offering them better care, ...
The US Centers for Medicare and Medicaid Services (CMS) is ending its requirement for coverage with evidence development for fluorodeoxyglucose positron emission tomography (FDG-PET) in oncology. In ...
FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
Immunotherapy using immune checkpoint inhibitors (ICI) targeting programmed cell death 1 receptor (PD-1) is now a well-established treatment for patients with metastatic melanoma 1. Indeed, clinical ...
A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable ...
Unveiling consistency: A large-scale analysis of conference proceedings and subsequent publications in oncology clinical trials using large language models. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results